Reeder, Thaddues Cromwell,Moore, Mark Wade,Lorenz, Douglas Alan,Lyon, David Keith
申请号：
AU2018222921
公开号：
AU2018222921A1
申请日:
2018.08.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018222921A120180920.pdf#####ABSTRACT In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine. 93
